Patient-centered Dosage of Levothyroxine

Levothyroxine is the most used thyroid hormone replacement when the thyroid gland is failing. Because dosage adjustment normally takes several months, the investigators have developed a decision support tool (DST) that predicts optimal dosage based on repeated blood samples the first 2 weeks after initiation of therapy. In this randomized study the investigators will include patients that start levothyroxine therapy after total thyroidectomy. The use of DST to advice the physician about an early dosage adjustment will be compared with common clinical practice, that is dosage adjustment every 2

Trial Details

NCT ID
NCT06455371
Phase
NA
Sponsor
University Hospital of North Norway
Status
RECRUITING
Cancer Type
Thyroid Cancer
Interventions
  • Decision support tool
Locations (sample)
  • Bergen, Norway|60.39299,5.32415
  • Oslo, Norway|59.91273,10.74609
  • Tromsø, Norway|69.6489,18.95508

Key Eligibility Criteria

  • Total or completion thyroidectomy for differentiated thyroid cancer og benign thyroid nodules at Norwegian hospitals

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Thyroid Cancer Trials on Trialify →